Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CFO Alexis Desieno sold 24,778 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. This trade represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Alexis Desieno also recently made the following trade(s):
- On Friday, January 3rd, Alexis Desieno sold 8,854 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18.
Cardlytics Trading Down 7.4 %
NASDAQ CDLX opened at $3.12 on Thursday. The company’s fifty day simple moving average is $3.45 and its 200-day simple moving average is $3.72. Cardlytics, Inc. has a 52 week low of $2.76 and a 52 week high of $20.52. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The stock has a market cap of $158.56 million, a P/E ratio of -0.51 and a beta of 1.54.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on CDLX
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in CDLX. Atom Investors LP acquired a new position in shares of Cardlytics during the third quarter worth $33,000. Tallon Kerry Patrick acquired a new stake in Cardlytics in the fourth quarter valued at $37,000. ProShare Advisors LLC acquired a new stake in Cardlytics in the fourth quarter valued at $43,000. SG Americas Securities LLC acquired a new stake in Cardlytics in the third quarter valued at $45,000. Finally, Intech Investment Management LLC acquired a new stake in Cardlytics in the third quarter valued at $47,000. 68.10% of the stock is owned by institutional investors and hedge funds.
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Recommended Stories
- Five stocks we like better than Cardlytics
- 5 Top Rated Dividend Stocks to Consider
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.